Top

Published in:

01-07-2018 | Original Article

Bone marrow mesenchymal stromal cells protect allograft lung transplants from acute rejection via the PD-L1/IL-17A axis

Authors: Naoya Ishibashi, Tatsuaki Watanabe, Masahiko Kanehira, Yui Watanabe, Yasushi Hoshikawa, Hirotsugu Notsuda, Masafumi Noda, Akira Sakurada, Shinya Ohkouchi, Takashi Kondo, Yoshinori Okada

Published in: Surgery Today | Issue 7/2018

Abstract

Purpose

Using a rat model of allograft lung transplantation, we investigated the effectiveness of mesenchymal stromal cells (MSCs) as prophylactic and therapeutic agents against the acute rejection of lung grafts.

Methods

Lung grafts were harvested from donor rats and transplanted orthotopically into major histocompatibility complex-mismatched rats. MSCs were administered to the recipients once (on day 0) or twice (on days 0 and 3) after transplantation. The grade of acute rejection was evaluated both macroscopically and microscopically 6 days after transplantation. To elucidate the related mechanism, mRNA levels of inflammatory cytokines and immunomodulatory receptors in the transplanted grafts were measured using quantitative RT-PCR.

Results

The lung graft tissue from the rats that received MSCs post-surgically was protected from acute rejection significantly better than that from the untreated controls. Notably, the rats administered MSCs twice after surgery exhibited the least signs of rejection, with a markedly upregulated mRNA level of PD-L1 and a downregulated mRNA level of IL-17A.

Conclusion

This study assessed MSC protection of lung allografts from acute rejection by modulating T cell activity via enforced expression of PD-L1 in transplants and downregulation of IL-17A.

Hartert M, Senbaklavacin O, Gohrbandt B, Fischer BM, Buhl R, Vahld CF. Lung transplantation: a treatment option in end-stage lung disease. Dtsch Arztebl Int. 2014;111(7):107–16. https://doi.org/10.3238/arztebl.2014.0107. (Epub 2014/03/14; PubMed PMID: 24622680; PubMed Central PMCID: PMCPmc3957052).PubMedPubMedCentralCrossRef

Yusen RD, Edwards LB, Kucheryavaya AY, Benden C, Dipchand AI, Dobbels F, et al. The registry of the international society for heart and lung transplantation: thirty-first adult lung and heart–lung transplant report–2014; focus theme: retransplantation. J Heart Lung Transpl. 2014;33(10):1009–24. https://doi.org/10.1016/j.healun.2014.08.004. (Epub 2014/09/23; PubMed PMID: 25242125).CrossRef

Prockop DJ, Oh JY. Mesenchymal stem/stromal cells (MSCs): role as guardians of inflammation. Mol Ther. 2012;20(1):14–20. https://doi.org/10.1038/mt.2011.211 (Epub 2011/10/20; PubMed PMID: 22008910; PubMed Central PMCID: PMCPmc3255583).CrossRefPubMed

Islam MN, Das SR, Emin MT, Wei M, Sun L, Westphalen K, et al. Mitochondrial transfer from bone-marrow-derived stromal cells to pulmonary alveoli protects against acute lung injury. Nat Med. 2012;18(5):759–65. https://doi.org/10.1038/nm.2736. (Epub 2012/04/17; PubMed PMID: 22504485; PubMed Central PMCID: PMCPmc3727429).CrossRefPubMedPubMedCentral

Oh JY, Kim MK, Shin MS, Lee HJ, Ko JH, Wee WR, et al. The anti-inflammatory and anti-angiogenic role of mesenchymal stem cells in corneal wound healing following chemical injury. Stem Cells (Dayton, Ohio). 2008;26(4):1047–55. https://doi.org/10.1634/stemcells.2007-0737. (Epub 2008/01/15; PubMed PMID: 18192235).CrossRef

Ohtaki H, Ylostalo JH, Foraker JE, Robinson AP, Reger RL, Shioda S, et al. Stem/progenitor cells from bone marrow decrease neuronal death in global ischemia by modulation of inflammatory/immune responses. Proc Natl Acad Sci USA. 2008;105(38):14638–43. https://doi.org/10.1073/pnas.0803670105. (Epub 2008/09/17; PubMed PMID: 18794523; PubMed Central PMCID: PMCPmc2567180).CrossRefPubMedPubMedCentral

Zhu XY, Lerman A, Lerman LO. Concise review: mesenchymal stem cell treatment for ischemic kidney disease. Stem Cells (Dayton, Ohio). 2013;31(9):1731–6. https://doi.org/10.1002/stem.1449 (Epub 2013/06/15. PubMed PMID: 23766020; PubMed Central PMCID: PMCPmc3795813) CrossRef

Ben Nasr M, Vergani A, Avruch J, Liu L, Kefaloyianni E, D’Addio F, et al. Co-transplantation of autologous MSCs delays islet allograft rejection and generates a local immunoprivileged site. Acta Diabetol. 2015;52(5):917–27. https://doi.org/10.1007/s00592-015-0735-y. (Epub 2015/03/27; PubMed PMID: 25808641; PubMed Central PMCID: PMCPmc4968999).CrossRefPubMedPubMedCentral

Muroi K, Miyamura K, Okada M, Yamashita T, Murata M, Ishikawa T, et al. Bone marrow-derived mesenchymal stem cells (JR-031) for steroid-refractory grade III or IV acute graft-versus-host disease: a phase II/III study. Int J Hematol. 2016;103(2):243–50. https://doi.org/10.1007/s12185-015-1915-9. (Epub 2015/11/27; PubMed PMID: 26608364).CrossRefPubMed

10.

Okada Y, Marchevsky AM, Zuo XJ, Pass JA, Kass RM, Matloff JM, et al. Accumulation of platelets in rat syngeneic lung transplants: a potential factor responsible for preservation-reperfusion injury. Transplantation. 1997;64(6):801–6. (Epub 1997/10/27; PubMed PMID: 9326401).CrossRefPubMed

11.

Oishi H, Okada Y, Kikuchi T, Hoshikawa Y, Sado T, Noda M, et al. Transbronchial human interleukin-10 gene transfer reduces acute inflammation associated with allograft rejection and intragraft interleukin-2 and tumor necrosis factor-alpha gene expression in a rat model of lung transplantation. J Heart Lung Transpl. 2010;29(3):360–7. https://doi.org/10.1016/j.healun.2009.10.002. (Epub 2010/03/06; PubMed PMID: 20202600).CrossRef

12.

Zha Y, Blank C, Gajewski TF. Negative regulation of T-cell function by PD-1. Crit Rev Immunol. 2004;24(4):229–37. (Epub 2004/12/14; PubMed PMID: 15588223).CrossRefPubMed

13.

Gianchecchi E, Delfino DV, Fierabracci A. Recent insights into the role of the PD-1/PD-L1 pathway in immunological tolerance and autoimmunity. Autoimmun Rev. 2013;12(11):1091–100. https://doi.org/10.1016/j.autrev.2013.05.003. (Epub 2013/06/25. PubMed PMID: 23792703).CrossRefPubMed

14.

Dong Y, Sun Q, Zhang X. PD-1 and its ligands are important immune checkpoints in cancer. Oncotarget. 2016. https://doi.org/10.18632/oncotarget.13895. (Epub 2016/12/16; PubMed PMID: 27974689).CrossRefPubMedPubMedCentral

15.

Akhmetzyanova I, Drabczyk M, Neff CP, Gibbert K, Dietze KK, Werner T, et al. PD-L1 expression on retrovirus-infected cells mediates immune escape from CD8 + T Cell killing. PLoS Pathog. 2015;11(10):e1005224. https://doi.org/10.1371/journal.ppat.1005224. (Epub 2015/10/21; PubMed PMID: 26484769; PubMed Central PMCID: PMCPmc4617866).CrossRefPubMedPubMedCentral

16.

Davies LC, Heldring N, Kadri N, Le Blanc K. Mesenchymal stromal cell secretion of programmed death-1 ligands regulates t cell mediated immunosuppression. Stem Cells (Dayton, Ohio). 2016. https://doi.org/10.1002/stem.2509. (Epub 2016/10/27; PubMed PMID: 27671847).CrossRef

17.

Bamoulid J, Staeck O, Halleck F, Khadzhynov D, Brakemeier S, Durr M, et al. The need for minimization strategies: current problems of immunosuppression. Transpl Int Off J Eur Soc Organ Transpl. 2015;28(8):891–900. https://doi.org/10.1111/tri.12553. (Epub 2015/03/11; PubMed PMID: 25752992).CrossRef

18.

Uluckan O, Wagner EF. Role of IL-17A signalling in psoriasis and associated bone loss. Clin Exp Rheumatol. 2016;34(4 Suppl 98):17–20. (Epub 2016/09/03; PubMed PMID: 27586798).PubMed

19.

Qian X, Chen H, Wu X, Hu L, Huang Q, Jin Y. Interleukin-17 acts as double-edged sword in anti-tumor immunity and tumorigenesis. Cytokine. 2017;89:34–44. https://doi.org/10.1016/j.cyto.2015.09.011. (Epub 2016/02/18; PubMed PMID: 26883678).CrossRefPubMed

20.

Srenathan U, Steel K, Taams LS. IL-17 + CD8 + T cells: differentiation, phenotype and role in inflammatory disease. Immunol Lett. 2016;178:20–6. https://doi.org/10.1016/j.imlet.2016.05.001. (Epub 2016/05/14; PubMed PMID: 27173097; PubMed Central PMCID: PMCPmc5046976).CrossRefPubMedPubMedCentral

21.

Nirula A, Nilsen J, Klekotka P, Kricorian G, Erondu N, Towne JE, et al. Effect of IL-17 receptor A blockade with brodalumab in inflammatory diseases. Rheumatology. 2016;55(suppl 2):ii43–ii55. https://doi.org/10.1093/rheumatology/kew346. (Epub 2016/11/20; PubMed PMID: 27856660).CrossRefPubMed

22.

Wasilewska A, Winiarska M, Olszewska M, Rudnicka L. Interleukin-17 inhibitors. A new era in treatment of psoriasis and other skin diseases. Postepy Dermatologii i Alergologii. 2016;33(4):247–52. https://doi.org/10.5114/ada.2016.61599. (Epub 2016/09/09; PubMed PMID: 27605893; PubMed Central PMCID: PMCPmc5004212).PubMedPubMedCentralCrossRef

Title: Bone marrow mesenchymal stromal cells protect allograft lung transplants from acute rejection via the PD-L1/IL-17A axis
Authors: Naoya Ishibashi
Tatsuaki Watanabe
Masahiko Kanehira
Yui Watanabe
Yasushi Hoshikawa
Hirotsugu Notsuda
Masafumi Noda
Akira Sakurada
Shinya Ohkouchi
Takashi Kondo
Yoshinori Okada
Publication date: 01-07-2018
Publisher: Springer Singapore
Published in: Surgery Today / Issue 7/2018
Print ISSN: 0941-1291
Electronic ISSN: 1436-2813
DOI: https://doi.org/10.1007/s00595-018-1643-x

At a glance: The STEP trials

Springer Medicine

Bone marrow mesenchymal stromal cells protect allograft lung transplants from acute rejection via the PD-L1/IL-17A axis

Abstract

Purpose

Methods

Results

Conclusion

At a glance: The STEP trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 7/2018

Systematic review of the feasibility and future of laparoscopic liver resection for difficult lesions

Laparoscopic hemi-splenectomy

Postpneumonectomy bronchopleural fistula in non-small cell lung cancer patients: incidence, survival, mortality, and treatment analysis

The POU5F1 gene expression in colorectal cancer: a novel prognostic marker

Treatment of mediastinal lymphatic malformation in children: an analysis of a nationwide survey in Japan

Additional lymph node dissection for primary colorectal cancer invading another colon region